FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

496011000001109: Grisovin 500mg tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16810901000001115 Grisovin 500mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58223101000001112 Grisovin 500mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Grisovin 500mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Is a Product containing precisely griseofulvin 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has active ingredient Griseofulvin false Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Is a Grisovin true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has specific active ingredient Griseofulvin true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Grisovin 500mg tablets (GlaxoSmithKline) 100 tablet Is pack of False Grisovin 500mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Grisovin 500mg tablets (GlaxoSmithKline) 100 tablet Has AMP True Grisovin 500mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start